parches glp-1 BoletínDeprensa El Invima informa sobre la comercialización ilegal de los PATCHES (LUMESSA), promocionados en internet como método para bajar de peso sin registro sanitario en Colombia. La entidad advierte que Why GLP-1 Patches Don't Deliver—Yet

SGLT2 inhibitors are indicated for three conditions: T2DM, chronic kidney disease, and chronic heart failure

But the real-world cause and effect is the same

Gastroparesis remains the most widely studied and clinically challenging manifestation, and treatment with currently available modalities can often be suboptimal

Type 2 diabetes, which Januvia treats, is a long-lasting condition

No clinical safety or efficacy issues were identified

What you can't independently verify without direct contact: individual batch COAs (certificates of analysis from third-party testing), specific country of origin for any given batch (brand states Brazil, Argentina, Colombia